QA: MERIDIAN BIOSCIENCE INC in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000794172_2023_MERIDIAN_BIOSCIENCE_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3095719795628404, 'aggregate_val': 463097000, 'exp_sum': 670739000, 'exp_to_value': {'AssetsCurrent': 210597000, 'AssetsNoncurrent': 207642000, 'PropertyPlantAndEquipmentNet': 44858000, 'Goodwill': 190433000, 'remainder_Assets': 17209000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.006045139833078837, 'aggregate_val': 95036000, 'exp_sum': 95614000, 'exp_to_value': {'LiabilitiesNoncurrent': 37085000, 'LiabilitiesCurrent': 58529000, 'remainder_Liabilities': 0}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000794172')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000794172, MERIDIAN BIOSCIENCE INC

  xvar xval
0 LiabilitiesNoncurrent 37,085,000
1 LiabilitiesCurrent 58,529,000
2 remainder_Liabilities -578,000
3 AssetsCurrent 210,597,000
4 AssetsNoncurrent 207,642,000
5 PropertyPlantAndEquipmentNet 44,858,000
6 Goodwill 190,433,000
7 remainder_Assets -190,433,000
8 GeneralAndAdministrativeExpense 233,083,000
9 ResearchAndDevelopmentExpense 24,335,000
10 remainder_Expenses 33,067,000
11 remainder_Revenues 333,018,000
12 remainder_NetIncome -74,000
13 remainder_ComprehensiveNetIncome -10,702,000
  yvar yval
0 Liabilities 95,036,000
1 Assets 463,097,000
2 Expenses 290,485,000
3 Revenues 333,018,000
4 StockholdersEquity 368,061,000
5 NetIncome 42,459,000
6 ComprehensiveNetIncome 37,108,000
7 BaseVar 596,206,000
8 EconomicCapitalRatio 1.25

Edgar->Model Mapping

Feature Distribution

Change over Time